Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30220707

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
2018 Sep
First author
Ziegler DS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Ziegler DS
      type
      Author
    2. name
      Wong M
      type
      Author
    3. name
      Mayoh C
      type
      Author
    4. name
      Kumar A
      type
      Author
    5. name
      Tsoli M
      type
      Author
    6. name
      Mould E
      type
      Author
    7. name
      Tyrrell V
      type
      Author
    8. name
      Khuong-Quang DA
      type
      Author
    9. name
      Pinese M
      type
      Author
    10. name
      Gayevskiy V
      type
      Author
    11. name
      Cohn RJ
      type
      Author
    12. name
      Lau LMS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Ziegler DS
      type
      Author
    2. name
      Wong M
      type
      Author
    3. name
      Mayoh C
      type
      Author
    4. name
      Kumar A
      type
      Author
    5. name
      Tsoli M
      type
      Author
    6. name
      Mould E
      type
      Author
    7. name
      Tyrrell V
      type
      Author
    8. name
      Khuong-Quang DA
      type
      Author
    9. name
      Pinese M
      type
      Author
    10. name
      Gayevskiy V
      type
      Author
    11. name
      Cohn RJ
      type
      Author
    12. name
      Lau LMS
      type
      Author
    bibliography ids
    1. nci-bib-4434de301cc945b12778d965
    book metadata
    content sha256
    3ace84aae7b2d2a37aa9a3f1b8bd646062cebcb3c2a0375afb85f5222f487efa
    document type
    citation
    dois
    1. 10.1038/s41416-018-0251-2
    electronic publication date
    display
    2018 Sep 17
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30220707
    immutable id
    pubmed:30220707@3ace84aae7b2d2a37aa9a3f1b8bd646062cebcb3c2a0375afb85f5222f487efa
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    6
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    693-696
    volume
    119
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30220707
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      31f7a3e80aece008a31cf164c662b5fe35dea980b72cb8d7b4f55030685aa274
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Sep
      precision
      month
      year
      2018
      publication types
      1. Case Reports
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30220707/
      title
      Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.

      Preserved source evidence · Not medical advice